Vegan Omegas + CoQ10
Natural health product licensed in Canada
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80062461
- Status
- Active licence
- Licence date
- 3 July 2015
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schizochytrium spp. Source : En entier Potency : 0 270-360 mg Docosahexaenoic acid | 900 mg | Not calculated |
| Schizochytrium spp. Source : En entier Potency : 0 135-270 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Schizochytrium spp. Source : En entier Potency : 0 450-540 mg EPA+DHA | Not specified | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 100 mg | Not calculated |
Non-medicinal ingredients
Huile de tournesol, Esters d'acide gras de saccharose, Lécithine, Amidon de maïs, Poly(sorbate) 20, Cellulose microcristalline, Laurate de saccharose, Glycérine, Fécule de pomme de terre, Béhénate de glycéryle, Extrait de romarin, Cire d'abeille, Caramel, Dioxyde de silicium, Carraghénine, Gélatine, Huile de lin, Palmitate d'ascorbyle, Sodium complexe de cuivre chlorophylline, Hypromellose, Stéaryl fumarate de sodium, Tocophérols, Esters d'acide gras de poly(glycérol), Chlorophylle, Mono- et di- glycérides, NA, Huile de carthame, Lysolécithine, Lécithine partiellement hydrolysées
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 3 days |
| Adultes | Not specified | 1 Capsule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support/maintain eye health/function. Helps support/maintain visual health/function. Helps support/maintain normal brain function. Helps support/maintain (normal) heart/ cardiovascular health/function. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic. An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, taking blood pressure medication or blood thinners. If taking this product for migraine prophylaxis: consult a health care practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen.
Source
Official Health Canada record, licence 80062461
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.